whoopsmeant Hexima matter (not Helix - lol have been referring to it as Helix shish) - see below:
http://hotcopper.com.au/posts/17929642/single
other issue I have and will be interested to see how it develops is whether there will be any involvement with related entities of officeholders - especially given that the Helix matter has been resolved BUT from my reading the terms of which have not been disclosed (if they were and I missed it please point me to them) - remember there was a "joint working relationship" on some products between ACR and Helix - common officeholder involved - and for some reason it broke down - however I still do not recall reading: 1) what the arrangements were; 2) who ended up with the "product"; 3) how much ACR had spent on that "venture"; 4) how much ACR ended "recouping" of its costs when the "venture" ceased will be interesting to see whether other "ventures" will be formed with other entities related to officeholders (if not already done so) and what terms there may be.
From 2014 Annual Report
In February 2014 it was announced that encouraging data had been generated for an antifungal product being developed in collaboration with Hexima Limited and that the next stage of product development had een initiated. Acrux subsequently filed an Australian provisional patent application to protect the joint rights of Acrux and Hexima to the intellectual property resulting from the collaboration. Hexima subsequently advised that it may not wish to further explore commercialisation of the antifungal medical product with Acrux. Acrux considers the best way to commercialise the technology remains through our collaboration agreement with Hexima and is continuing negotiations with Hexima to achieve this. Development of a non-melanoma skin cancer therapeutic project with Hexima has been suspended pending commercial resolution for the development of the antifungal medical product.
FROM 31/12/14 half year financial report
The two Hexima projects remain on hold, pending resolution of our dispute.
Common officeholder in the two companies from 2014 annual report officeholder profiles (but may have since resigned?) So would just like clarification on all this - not a big ask I would have thought.
Add to My Watchlist
What is My Watchlist?
